In today’s briefing:
- Quiddity Leaderboard S&P 500 Dec 24 Rebal – Final Predictions
- S&P500 December 2024 Forecast (Final): Flipping the COIN
- Janux Therapeutics: Transforming Prostate Cancer Treatment With Unprecedented Results!
- SpaceX: Rocket Ship – [Business Breakdowns, EP.194]
- Oil Prices Recover from Last Week’s Fall as Markets Bet on OPEC Postponing Output Hikes
- GM’s $1 Billion Stake Sale and $5.5 Billion Write-Off: China’s Auto Market Crisis Deepens!
- Super Micro Computer (SMCI): Investigation Clears Fraud Claims, But Is the Stock Still a Risk?
- Epr Properties (EPR) – Thursday, Sep 5, 2024
- Microchip Hits Pause on CHIPS Act Funds & Faces Big Challenges: A Red Flag For Investors?
- Intel CFO @ UBS Global Technology Conference “Core Strategy Remains Intact”
Quiddity Leaderboard S&P 500 Dec 24 Rebal – Final Predictions
- The S&P 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.
- The rankings used for the December 2024 index rebal event will be based on yesterday’s (4th December 2024) opening prices. Announcement date will be
- Inside we take a final look at the potential ADDs and DELs leading the rankings for the upcoming review.
S&P500 December 2024 Forecast (Final): Flipping the COIN
- Coinbase Global (COIN US) can be the unexpected addition by transition because of a high liquidity score and a close distance below the estimated transition threshold.
- Lennox International (LII US) is the main candidate for addition by migration due to having the highest average mcap score and passing eligibility metrics.
- Illumina Inc (ILMN US) has a muted conviction for addition because of ineligible earnings and a recent deletion from the index.
Janux Therapeutics: Transforming Prostate Cancer Treatment With Unprecedented Results!
- Janux Therapeutics has taken the biopharmaceutical industry by storm with its recent announcement of groundbreaking results from its Phase 1 clinical trial of JANX007, a tumor-activated T-cell engager targeting advanced prostate cancer.
- The data reveals a stunning 100% PSA50 response rate among heavily pretreated patients, with 63% achieving PSA90 and 31% achieving PSA99—a significant milestone in prostate cancer treatment.
- The company has prioritized the development of second- and third-line therapies for metastatic castration-resistant prostate cancer (mCRPC), aiming to address a substantial unmet need in oncology.
SpaceX: Rocket Ship – [Business Breakdowns, EP.194]
- Business Breakdowns series delves into SpaceX with investor Luke Ward from Bailey Gifford
- Focus on SpaceX’s business model, cost curve of launches, and potential future of the space economy
- SpaceX is a business and technology innovator, with a focus on economic sustainability and funding additional technology innovation to expand market capabilities, such as with Starlink.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.
Oil Prices Recover from Last Week’s Fall as Markets Bet on OPEC Postponing Output Hikes
- OPEC+ will meet today (05/Dec), following a postponement from 01/Dec, to decide whether to delay planned output increases further.
- The postponement caused market jitters, with WTI and Brent futures falling 1.1% and 0.6%, respectively, on 29/Nov. The uncertainty eased as the delay was attributed to scheduling conflicts.
- For the week starting 02/Dec, WTI and Brent crude oil futures rebounded, rising 0.9% and 0.8%, respectively, driven by expectations of OPEC+ delaying planned output hikes due to price declines.
GM’s $1 Billion Stake Sale and $5.5 Billion Write-Off: China’s Auto Market Crisis Deepens!
- General Motors (GM) is navigating turbulent waters as it steers towards an electric vehicle (EV)-focused future.
- Recent developments, such as the sale of its stake in a Michigan battery cell plant for $1 billion to LG Energy Solution, underline GM’s efforts to streamline its operations and adapt to evolving market conditions.
- Meanwhile, the company announced a significant write-off of $2.8 billion for its Chinese joint venture with SAIC Motor and an additional $2.7 billion restructuring charge to address declining profitability in one of its largest markets.
Super Micro Computer (SMCI): Investigation Clears Fraud Claims, But Is the Stock Still a Risk?
- Super Micro Computer (SMCI) has been in the spotlight recently, with its stock experiencing wild swings amid developments that have left investors divided.
- On one hand, a special committee investigation concluded there was no evidence of fraud or misconduct, a finding that alleviated fears sparked by Ernst & Young’s resignation as its auditor.
- This positive news was coupled with robust growth in AI-driven revenues, innovative liquid-cooled server solutions, and ambitious manufacturing expansion plans.
Epr Properties (EPR) – Thursday, Sep 5, 2024
- Investors are cautious about EPR Properties due to concerns about the movie theater industry’s impact on its financial performance
- EPR has a diversified portfolio, strong lease metrics, and potential for growth in other leisure sectors
- Despite short-term industry challenges, EPR Properties offers long-term value and potential for growth with solid underlying property fundamentals and a track record of success
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.
Microchip Hits Pause on CHIPS Act Funds & Faces Big Challenges: A Red Flag For Investors?
- Microchip Technology reported its second-quarter fiscal year 2025 financial results amidst a challenging macroeconomic environment.
- The company faced a sequential net sales decline of 6.2% to $1.164 billion.
- Excluding a $13.3 million benefit from the settlement of a legal matter with a licensee, net sales declined by7.3%.
Intel CFO @ UBS Global Technology Conference “Core Strategy Remains Intact”
- Earlier this week, at the UBS Global Technology Conference, Intel CFO and co-interim CEO David Zinsner declared that the company’s “core strategy remains intact”
- Recently onboarded GM of IFS Dr. Naga Chandrasekaran, explained that while 18A remains on track, there are still “many milestones” to be met before it ramps in H225
- He also admitted that 18A is more geared towards HPC, is skewed in favour of Intel Products and that 14A will likely be more suitable for the broader semiconductor ecosystem